Peritoneal Tumors

This refers to tumors or cancers that start in the peritoneum, the lining of your abdomen. These can be serious and require medical treatment.

Condition

What people with Peritoneal Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Debulking Surgery for Peritoneal Tumors?

NameHow it went

About Peritoneal Tumors

What It Is

Peritoneal tumors are growths on the peritoneum, the thin, smooth lining that covers the inside of the abdominal wall and wraps around organs such as the intestines, liver and stomach. The term usually refers to cancer. When cancer has spread across this lining in many places, doctors often call it peritoneal carcinomatosis or a peritoneal surface malignancy. Most of the time, the cancer did not start in the peritoneum. It spread there from another organ, most often the ovary, colon or rectum, appendix or stomach, and it is treated according to where it began. A few cancers start in or near the lining itself: primary peritoneal cancer, which behaves like the most common type of ovarian cancer and is treated the same way; peritoneal mesothelioma, a cancer of the lining's own cells; and pseudomyxoma peritonei, in which a mucus-producing tumor, usually from the appendix, gradually fills the abdomen with jelly-like material. Because the lining covers such a large area, tumors can grow in many small patches before they cause trouble. When symptoms appear, they are often vague: a belly that slowly gets bigger, bloating, feeling full after small meals, pain or pressure in the abdomen or pelvis, and changes in bowel habits. Much of the swelling often comes from fluid that the cancer causes to collect in the abdomen, called malignant ascites.

Causes & Risk Factors

Because most peritoneal tumors come from another cancer, the main risk is having a cancer of the abdomen or pelvis, especially ovarian, colorectal, appendix or stomach cancer. Cancer cells can shed from the original tumor into the fluid inside the abdomen and settle on the lining. This may already be present when the first cancer is found, or it may appear later as a recurrence. Less often, cancers from outside the abdomen, such as breast or lung cancer, spread there. The forms that start in the peritoneum have their own risk factors. Primary peritoneal cancer shares risk factors with ovarian cancer, including inherited changes in the BRCA1 or BRCA2 genes, Lynch syndrome (an inherited condition that raises the risk of colon and several other cancers), a family history of ovarian cancer and older age. Peritoneal mesothelioma is strongly linked to past exposure to asbestos, a mineral fiber once widely used in building and industry, and it usually appears many years after that exposure. Pseudomyxoma peritonei usually begins when a slow-growing, mucus-producing tumor of the appendix breaks through the appendix wall. A risk factor raises the chance of a cancer but does not mean it will develop, and not having a known risk factor does not rule one out.

How It's Diagnosed

Peritoneal tumors can be difficult to pin down, and they are sometimes first discovered during surgery for another reason. A CT scan of the abdomen and pelvis is usually the first detailed test. MRI can show some areas, such as the pelvis, more clearly, and a PET scan helps in some situations. Several noncancerous conditions, including tuberculosis of the abdomen and endometriosis, can look similar on scans, which is one reason imaging alone is not enough. If fluid has built up, a doctor may drain some through a needle (a procedure called paracentesis) and check it for cancer cells. Blood tests for tumor markers can support the picture: CA-125 is often raised in ovarian-type cancers, and CEA or CA 19-9 in cancers from the digestive tract. These markers can also be raised by other conditions, so they cannot confirm the diagnosis; they are more useful for tracking the cancer once it is known. The diagnosis is confirmed by examining tissue under a microscope. The sample is often taken through laparoscopy, a keyhole operation that lets the surgeon look at the lining directly, or during a larger operation. Surgeons also estimate how much of the lining is involved, often with a score called the peritoneal cancer index (PCI), in which higher numbers mean more widespread disease. That extent, together with the tumor type and grade, strongly shapes which treatments make sense. Tests on the tumor, and for some people tests for inherited gene changes, help identify where the cancer came from and which medicines may work.

Treatment Options

Treatment depends mainly on where the cancer started, how much of the lining is involved, whether it has spread elsewhere and the person's overall health. Because these cancers are uncommon and the choices are complex, plans are best made by a specialized team that regularly treats peritoneal cancers, bringing together surgeons, cancer specialists, radiologists and pathologists. For selected people, the treatment aimed at long-term control is cytoreductive surgery: an extensive operation to remove all visible tumor from the lining, along with any affected organs. It is sometimes combined with HIPEC (hyperthermic intraperitoneal chemotherapy), in which heated chemotherapy is circulated through the abdomen at the end of the operation to reach cancer cells too small to see. How much HIPEC adds depends on the cancer. It is the standard approach for eligible people with pseudomyxoma peritonei, it is used with surgery for peritoneal mesothelioma, and it is an option for some advanced ovarian cancers after an initial course of chemotherapy. For colorectal cancer, a major trial did not show a benefit from adding one widely used form of HIPEC to complete surgery, so its use there is generally limited to clinical trials. Surgery helps most when all visible disease can be removed. It is a major operation with a real risk of complications, including kidney injury from HIPEC, and it is not suitable when the cancer is too widespread or a person is not strong enough for it. Chemotherapy given through a vein or by mouth treats cancer throughout the body and is the main treatment for many people, either on its own or before and after surgery. Depending on the original cancer, it may be combined with targeted drugs or immunotherapy. For ovarian-type and primary peritoneal cancers, PARP inhibitors, pills that block a DNA repair system cancer cells depend on, may be used as maintenance treatment to hold the cancer back after chemotherapy. Clinical trials are a reasonable option to ask about for many of these cancers. Care for symptoms runs alongside cancer treatment. Fluid in the abdomen can be drained through a needle, which relieves pressure for most people, although the fluid often returns within weeks; a small tube left in place lets some people drain fluid at home and avoid repeated procedures. Medicines can ease the nausea, vomiting and cramping of a blocked bowel when surgery is not an option, and palliative care teams can help with symptoms at any stage, not only near the end of life.

What to Expect

The outlook varies more than the shared name suggests. Cancer that has spread widely to the peritoneum from the stomach or colon is usually serious and difficult to cure, and treatment often aims to control it and keep people feeling as well as possible for as long as possible. Low-grade pseudomyxoma peritonei, by contrast, tends to grow slowly and often carries a favorable outlook after complete surgery, while high-grade forms behave more aggressively. Across types, how much of the lining is involved and whether surgery removes all visible tumor are among the strongest influences on outcome. Recovery from cytoreductive surgery takes time, and appetite, energy and bowel habits can take a while to settle. Even after successful treatment, these cancers can come back, so follow-up typically continues for years with check-ups, scans and tumor marker blood tests. For pseudomyxoma peritonei, guidelines suggest surveillance for at least five years. For people living with advanced disease, daily life is often shaped by symptoms such as fluid buildup, poor appetite, weight loss and bowel problems. Fluid that keeps returning usually reflects more advanced disease. Talking early with the care team, including palliative care, about goals, symptom control and what matters most helps people make choices that fit their priorities as things change.

When to Seek Help

See a doctor if a swelling belly, bloating, feeling full quickly, pain or pressure in the abdomen or pelvis, or a change in bowel habits is new and lasts, or keeps getting worse, particularly if you have had an abdominal or pelvic cancer. If you are being treated or monitored for a peritoneal tumor, contact your care team promptly if fluid seems to be building up again quickly, or if you develop fever, redness or leaking around a drainage tube. Contact your care team right away if you keep vomiting, cannot pass stool or gas, or have cramping abdominal pain that does not ease, because these can mean the bowel is blocked, which often needs treatment in hospital.

Questions to Ask Your Doctor

  1. 1.Where did this cancer start, and how does that change my treatment options?
  2. 2.How much of the lining is involved, and could surgery to remove it, with or without HIPEC, help in my situation?
  3. 3.Should my case be reviewed at a center that specializes in peritoneal cancers?
  4. 4.Should I have genetic testing, and what would the results mean for my treatment and my family?
  5. 5.How will we manage fluid buildup or bowel problems if they happen, and when should I call?

Last reviewed • Oct 2026

Educational content, not medical advice.